MDXG - MiMedx Group GAAP EPS of -$0.11 misses by $0.04 revenue of $66.88M beats by $1.81M
- MiMedx Group press release ( NASDAQ: MDXG ): Q2 GAAP EPS of -$0.11 misses by $0.04 .
- Revenue of $66.88M (-1.9% Y/Y) beats by $1.81M .
- The company is maintaining its outlook for FY2022, as disclosed in its earnings release for the year ended December 31, 2021, including that it expects net sales of its continuing portfolio of Advanced Wound Care products, which were $240M in 2021, to grow 11% to 14% in 2022.
- These expectations reflect the company's plans to launch AMNIOEFFECT and its Placental Collagen Matrix product, AXIOFILL, in the U.S. in September, as well as the launch of EPIFIX® in Japan later this year.
For further details see:
MiMedx Group GAAP EPS of -$0.11 misses by $0.04, revenue of $66.88M beats by $1.81M